The head of the Tehran Chamber of Commerce warned that we will face a shortage of medicines if this trend continues.
The president of the Tehran Chamber of Commerce criticized the current state of the country’s pharmaceutical industry and stated that if this trend persists, we will face a shortage of medicines.
Mohammad Najafi Arab, the head of the Tehran Chamber of Commerce, commented on the poor state of the country’s pharmaceutical industry and explained that the Ministry of Health has allocated $45 billion in preferential exchange rates for importing health-related goods, medicines, and medical equipment. A small portion of this currency is at the rate of 4200 tomans, while most of it is at the rate of 28500 tomans. However, there are difficulties in allocating and supplying this currency and in its timing.
He added that besides the significant importance that capital circulation has gained in the pharmaceutical industry these days, capital flow is crucial. The return of resources is severely affected due to delays in payments by state insurance companies and hospitals for drug purchases from distribution companies, leading to difficulties in the flow of work for production companies and import companies.
The pharmaceutical industry expert ultimately reminded that the continuation of these problems could lead to a drug shortage because the current state of the country’s pharmaceutical industry is not good. For this reason, a few days ago, pharmaceutical companies in the country, such as manufacturers of raw materials, producers, and importers of drugs, in a letter addressed to the president and signed by all, expressed their problems.
